99% Savings - Buy Just @1 Rs X
Pegmove Powder for Oral Solution is a commercial drug that is prescribed in the form of Powder. Primarily, it is used for the treatment of Constipation.
The optimal dosage of Pegmove Powder for Oral Solution is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Pegmove Powder for Oral Solution can also lead to other problems, which have been listed below. These side effects of Pegmove Powder for Oral Solution are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Pegmove Powder for Oral Solution's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Pegmove Powder for Oral Solution has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pegmove Powder for Oral Solution related warnings section.
Some other conditions that can be affected by Pegmove Powder for Oral Solution are listed in the contraindications section below.
Drug reaction of Pegmove Powder for Oral Solution with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Pegmove Powder for Oral Solution is considered not safe while driving, and is not addictive.
Pegmove Powder for Oral Solution is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pegmove Powder for Oral Solution safe for pregnant women?
Pegmove may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Pegmove again without your doctor's advice.
Is the use of Pegmove Powder for Oral Solution safe during breastfeeding?
Pegmove may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Pegmove, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Pegmove.
What is the effect of Pegmove Powder for Oral Solution on the Kidneys?
Pegmove rarely affects the kidneys.
What is the effect of Pegmove Powder for Oral Solution on the Liver?
Pegmove does not damage the liver.
What is the effect of Pegmove Powder for Oral Solution on the Heart?
Using Pegmove does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Pegmove Powder for Oral Solution unless your doctor advises you to do so -
Is this Pegmove Powder for Oral Solution habit forming or addictive?
Pegmove Powder for Oral Solution is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pegmove Powder for Oral Solution you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Pegmove Powder for Oral Solution is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Pegmove Powder for Oral Solution is not used to treat mental disorders.
Interaction between Food and Pegmove Powder for Oral Solution
Information is not available on the interaction of any foods with Pegmove Powder for Oral Solution, due to a lack of research on this.
Interaction between Alcohol and Pegmove Powder for Oral Solution
No research has been done on this till date. Therefore, it is not known what the effect of taking Pegmove Powder for Oral Solution with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polyethylene Glycol 3350
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1036